Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12611000397910
Ethics application status
Approved
Date submitted
14/04/2011
Date registered
15/04/2011
Date last updated
5/05/2014
Type of registration
Prospectively registered

Titles & IDs
Public title
Should ankle syndesmosis screws be removed? A randomised, controlled trial.
Scientific title
In patients with syndesmosis screw fixation for ankle fracture diastasis, is removal of the syndesmosis screws at 3 months post surgery more effective than no screw removal in terms of functional outcomes?
Secondary ID [1] 260008 0
Nil
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Ankle fractures requiring syndesmosis screw fixation. 265667 0
Condition category
Condition code
Surgery 265800 265800 0 0
Surgical techniques
Injuries and Accidents 265801 265801 0 0
Fractures

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
No removal of ankle syndesmosis screws.
Intervention code [1] 264426 0
Treatment: Surgery
Comparator / control treatment
Removal of ankle syndesmosis screws at three months following fixation surgery.
Control group
Active

Outcomes
Primary outcome [1] 266554 0
Olerud-Molander ankle score (OMAS).
Timepoint [1] 266554 0
Assessments performed at 6 months and 12 months postoperatively.
Secondary outcome [1] 276021 0
American Orthopaedic Foot and Ankle Society (AOFAS) score of hindfoot.
Timepoint [1] 276021 0
Assessments performed at 6 months and 12 months postoperatively.
Secondary outcome [2] 276022 0
Ankle range of motion (measured with goniometer).
Timepoint [2] 276022 0
Assessments performed at 6 months and 12 months postoperatively.
Secondary outcome [3] 276023 0
Radiological loss of reduction.
Timepoint [3] 276023 0
Assessments performed at 6 weeks, 6 months, and 12 months postoperatively.
Secondary outcome [4] 276024 0
Radiological implant failure. Rate of implant failure (e.g. screw breakage or loosening, with or without a second surgery for removal) will be measured for each group. Broken screws will be defined as those in which there is a fracture of the screw. Loosened screws will be defined as those surrounded by a radiolucent zone 1 mm in width extending the length of threads in either the fibula or tibia. For the group randomised for screw removal, the rate of implant failure will only be measured at 6 weeks postoperatively.
Timepoint [4] 276024 0
Assessments performed at 6 weeks, 6 months, and 12 months postoperatively.

Eligibility
Key inclusion criteria
Male or female patients; greater than or equal to 16 years of age; ankle fracture with diastasis for planned syndesmosis screw fixation; AP, lateral and mortise X-ray views of the ankle taken preoperatively; closed fractures; consent form signed.
Minimum age
16 Years
Maximum age
65 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Ankle fractures not requiring syndesmosis screw fixation; compound fractures; pathologic fractures; fracture in a polytraumatised patient; fracture of a bone in the same lower limb (other than ankle fracture complex); patients > 65 years of age; past history of fracture or significant injury or disability of the same ankle; medical conditions too serious for surgery; patients who are unfit to consent; pregnant women.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
All patients with ankle fractures, who fit the inclusion and exclusion criteria, requiring syndesmosis screw fixation will be offered a chance to participate in the study. Following informed patient consent, the principle investigator will be contacted with the patient's details. The principle investigator will randomise the patient into one of the two study groups. Randomisation will not be revealed to the operating surgeons, admitting team, or anyone else involved in patient management. Randomisation will only be revealed following the patient's 6 week postoperative clinic review.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Randomisation will be performed by a source independent to patient clinical management, and will be concealed from the operating surgeons and admitting team. Randomisation will be performed using a random number generator with restricted blocks. The study will be performed according to an intention-to-treat protocol.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
6/06/2011
Actual
24/08/2011
Date of last participant enrolment
Anticipated
Actual
30/11/2012
Date of last data collection
Anticipated
Actual
Sample size
Target
100
Accrual to date
Final
Recruitment outside Australia
Country [1] 3388 0
New Zealand
State/province [1] 3388 0

Funding & Sponsors
Funding source category [1] 264896 0
Self funded/Unfunded
Name [1] 264896 0
Country [1] 264896 0
Primary sponsor type
Hospital
Name
Middlemore Hospital
Address
Private Bag 93311
Otahuhu
Auckland 1640
Country
New Zealand
Secondary sponsor category [1] 263996 0
Hospital
Name [1] 263996 0
Manukau Surgical Centre
Address [1] 263996 0
Private Bag 93311
Otahuhu
Auckland 1640
Country [1] 263996 0
New Zealand

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 266853 0
New Zealand Health and Disability Ethics Committees
Ethics committee address [1] 266853 0
Ethics committee country [1] 266853 0
New Zealand
Date submitted for ethics approval [1] 266853 0
10/05/2011
Approval date [1] 266853 0
Ethics approval number [1] 266853 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 32495 0
Dr Matthew J. Boyle
Address 32495 0
Department of Orthopaedics
Middlemore Hospital
Private Bag 93311
Otahuhu
Auckland 1640
Country 32495 0
New Zealand
Phone 32495 0
+64 9 276 0000
Fax 32495 0
Email 32495 0
[email protected]
Contact person for public queries
Name 15742 0
Matthew Boyle
Address 15742 0
Department of Orthopaedics
Middlemore Hospital
Private Bag 93311
Otahuhu
Auckland 1640
Country 15742 0
New Zealand
Phone 15742 0
64 9 276 0000
Fax 15742 0
Email 15742 0
[email protected]
Contact person for scientific queries
Name 6670 0
Matthew Boyle
Address 6670 0
Department of Orthopaedics
Middlemore Hospital
Private Bag 93311
Otahuhu
Auckland 1640
Country 6670 0
New Zealand
Phone 6670 0
64 9 276 0000
Fax 6670 0
Email 6670 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.